查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1939560

全球胆道支架系统市场（按支架类型、植入方式、应用、最终用户和分销管道划分）预测（2026-2032年）

Covered Biliary Stent System Market by Stent Type, Deployment Procedure, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025年，覆膜胆道支架系统市值为3.693亿美元，预计2026年将成长至3.9206亿美元，年复合成长率为5.81%，到2032年将达到5.485亿美元。

关键市场统计数据
基准年 2025 3.693亿美元
预计年份：2026年 3.9206亿美元
预测年份 2032 5.485亿美元
复合年增长率 (%) 5.81%

本文简要概述了临床创新、医疗设备性能和医疗服务动态之间复杂的相互作用如何影响胆道支架系统。

胆道支架系统的现状正处于临床实践、医疗设备工程和医疗系统物流的关键交会点。材料科学和内视镜技术的进步重塑了介入团队治疗胆道阻塞的方式，而不断完善的临床指南和日益精细化的手术操作也拓展了支架置入的适应症范围。同时，供应商网路、医院采购通讯协定和通路也变得日益复杂，这要求製造商和医疗服务提供者在临床疗效和营运效率之间取得平衡。

技术成熟度、流程改善和商业性差异化将如何重新定义胆道支架系统的临床价值和竞争优势

胆道支架领域近期发生的变革性变化，是技术成熟、手术流程标准化和市场主导共同作用的结果。在技​​术方面，涂层、聚合物科学和支架结构方面的创新降低了支架移位和阻塞的风险，同时提高了透过更小尺寸内视镜进行输送的便利性。影像和内视镜技术的同步进步提高了手术精度，实现了支架在目标部位的精准放置，并扩大了可治疗的解剖范围。这些技术进步也伴随着对以患者为中心的终点指标的日益重视，例如提高患者的生活品质和减少再次手术。

预计到2025年，关税主导的供应链重组和筹资策略重组将对製造业、采购和竞争地位产生影响。

预计到2025年，美国将对关税进行调整，这将对依赖全球供应链的製造商、经销商和医疗保健系统产生实际影响。关税将改变进口零件和成品的到岸成本，迫使製造商重新评估其定价、筹资策略和区域製造地。为此，一些供应商可能会加快关键零件的本地化生产或协商新的供应协议以保障利润率，而另一些供应商则可能重新设计包装或物流以减轻关税负担。

全面的細項分析揭示了设备类型、临床适应症、临床环境、通路和手术流程如何驱动采用趋势。

关键細項分析揭示了器械类型、临床应用、最终用户、分销管道和实施流程等方面的不同趋势，这些因素共同塑造了器械的采纳和创新路径。依支架类型分析，可分为生物可吸收支架、药物释放型支架、金属支架和塑胶支架，其中金属支架可进一步细分为覆膜金属支架和裸金属支架。通畅率、移位风险和可回收性等效能权衡会影响临床偏好和器械选择标准。在适应症方面，良性和恶性狭窄的治疗模式有所不同。良性病例包括慢性胰臟炎和胆结石，而恶性病例包括胆管癌和胰臟癌。这些临床情况决定了器械的预期寿命、併发症接受度和跨学科护理协调。

区域评估支付模式、监管多样性、手术普及程度和本地生产对市场进入和商业化策略的影响

区域趋势对胆道支架领域的临床通讯协定、监管路径和商业模式有显着影响。在美洲，医院系统的整合以及对综合支付模式的重视，正在推动能够显着降低再入院率和再次手术率的解决方案。该地区的临床医生和采购团队通常要求提供强有力的上市后证据和便捷的服务支持，从而促使对培训和生命週期项目进行投资。同时，在欧洲、中东和非洲，法规环境不均衡，支付方结构也各不相同，区域报销规则和基础设施能力决定支架技术的选择和应用速度。

设备创新、临床证据产生和综合服务模式如何塑造竞争格​​局和长期商业性伙伴关係

胆道支架系统的竞争主要取决于临床差异化、供应链实力以及提供全面客户支援的能力。投资于器材创新、可靠的临床证据和综合培训计画的主要企业，在产能庞大的生产设施和专业网路中占据有利地位。同时，灵活的区域性企业则利用製造地接近性和成本优势，瞄准价格敏感型市场，并根据临床医生的回馈快速改进产品设计。

在市场压力日益增大的情况下，製造商和供应商如何采取切实可行的策略来推动产品应用、建立支付方信任并加强供应链？

为了应对短期挑战并掌握不断变化的机会，产业领导者应优先考虑临床差异化和营运韧性这两大关键要素。首先，投资真实世界证据计画和多中心註册研究，以展示相关临床亚群的疗效。这种方法将增强临床可信度，并为医保报销谈判提供支援。其次，透过儘早与关键意见领袖 (KOL) 接洽，并整合回馈机制以支援迭代式设计改进，从而使产品开发与流程顺畅衔接。第三，透过区域筹资策略和紧急时应对计画提高供应链柔软性，以降低关税和物流波动带来的风险。

一种透明、以证据主导的研究途径，整合了临床医生访谈、设备技术分析和监管法规梳理，以支持策略决策。

本研究系统性地整合了一级资讯来源和二级资讯来源，力求平衡临床医师的见解、商业资讯和技术设备评估。一级资讯来源包括对介入内视镜医师、采购人员和设备技术人员的访谈，从而获得关于临床重点、设备操作注意事项和医院采购行为的第一手观点。二级资讯来源包括同行评审的临床文献、监管申报文件、产品规格和行业出版物，用于检验技术声明并梳理监管路径。整合过程优先考虑高品质证据和对声明的交叉检验，以得出可靠的结论。

本文简要总结了临床、营运和商业性因素，这些因素将决定哪些企业能够将创新转化为持续应用并改善患者预后。

总之，胆道支架系统产业的特点是技术创新迅速、临床差异化程度高以及商业性化程度不断提高。新材料、涂层技术和手术流程的改进正在融合，以拓展治疗可能性并改善患者预后，同时也需要加强对培训、实证医学和供应链适应性的投入。关税趋势和区域市场结构进一步增加了策略规划的复杂性，凸显了灵活采购和客製化打入市场策略的必要性。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依支架类型分類的覆膜胆道支架系统市场

  • 生物可吸收支架
  • 药物释放型支架
  • 金属支架
    • 覆膜金属支架
    • 未涂层金属支架
  • 塑胶支架

9. 依安装程序分類的覆膜胆道支架系统市场

  • 内视镜逆行性胰造影
  • 经皮肝内造影

10. 覆膜胆道支架系统市场（依应用划分）

  • 良性狭窄
    • 慢性胰臟炎
    • 胆结石
  • 恶性狭窄
    • 胆管癌
    • 胰臟癌

11. 依最终用户分類的覆膜胆道支架系统市场

  • 门诊手术中心
  • 医院
  • 专科诊所

12. 按分销管道分類的覆膜胆道支架系统市场

  • 直销
  • 电子商务
  • 医院频道
  • 零售药房

13. 各地区有盖胆道支架系统市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

14. 覆膜胆道支架系统市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 各国有盖胆道支架系统市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

16. 美国覆膜胆道支架系统市场

17. 中国覆膜胆道支架系统市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • CONMED Corporation
  • Cook Medical LLC
  • ELLA-CS, sro
  • Endo-Flex GmbH
  • Fujifilm Holdings Corporation
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Micro-Tech（Nanjing）Co., Ltd.
  • Olympus Corporation
  • Taewoong Medical Co., Ltd.
  • WL Gore & Associates, Inc.
Product Code: MRR-9A6A6F297857

The Covered Biliary Stent System Market was valued at USD 369.30 million in 2025 and is projected to grow to USD 392.06 million in 2026, with a CAGR of 5.81%, reaching USD 548.50 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 369.30 million
Estimated Year [2026] USD 392.06 million
Forecast Year [2032] USD 548.50 million
CAGR (%) 5.81%

A concise orientation to the complex convergence of clinical innovation, device performance, and healthcare delivery dynamics influencing biliary stent systems

The biliary stent systems landscape occupies a critical intersection of clinical practice, device engineering, and health system logistics. Advances in material science and endoscopic techniques have reshaped how interventional teams approach biliary obstruction management, while evolving clinical guidelines and growing procedural expertise have broadened indications for stent deployment. At the same time, supplier networks, hospital purchasing protocols, and distribution channels have become more complex, compelling manufacturers and providers to synchronize clinical performance with operational efficiency.

Consequently, stakeholders must balance clinical outcomes with device lifecycle considerations, regulatory compliance, and procurement realities. Clinicians prioritize stent patency and complication reduction, whereas hospital administrators focus on total cost of care and the ease of integration into existing procedural workflows. As technologies such as bioabsorbable scaffolds and drug-eluting coatings mature, they introduce new clinical value propositions but also require updated pathways for training, inventory management, and reimbursement coding. Therefore, a clear understanding of device attributes, procedural contexts, and end-user environments is essential to navigate adoption hurdles and to identify the most promising opportunities for innovation and commercialization.

How technological maturation, procedural refinement, and commercial differentiation are redefining clinical value and competitive advantage across biliary stent systems

Recent transformative shifts in the biliary stent field reflect a combination of technological maturation, procedural standardization, and market-driven imperatives. On the technology front, innovations in coatings, polymer science, and stent architecture have reduced migration and occlusion risks while improving deliverability through narrower endoscopes. Parallel improvements in imaging and endoscopic techniques have increased procedural precision, enabling targeted placement and extending the range of treatable anatomies. These technical gains have been accompanied by a stronger emphasis on patient-centric endpoints such as quality of life and reduced repeat interventions.

Operationally, stakeholders have adapted to changing procurement expectations by emphasizing lifecycle support, training programs, and bundled service models. Payers and health systems increasingly request evidence of long-term clinical benefit and real-world performance, motivating manufacturers to invest in post-market surveillance and registry data. At the same time, competitive dynamics have pushed suppliers to differentiate through integrated solutions that combine device performance with digital tools, procedural training, and streamlined supply chain arrangements. Moving forward, the market will likely favor players who can couple demonstrable clinical advantages with clear operational value and scalable support models.

Projected tariff-driven supply chain realignments and procurement recalibrations that will affect manufacturing, sourcing, and competitive positioning through 2025

Anticipated tariff adjustments in the United States through 2025 create tangible implications for manufacturers, distributors, and health systems that rely on global supply chains. Tariffs can alter landed costs for imported components and finished devices, prompting manufacturers to reassess pricing, sourcing strategies, and regional manufacturing footprints. In response, some suppliers may accelerate localization of critical components or negotiate new supplier contracts to shield margins, while others could redesign packaging and logistics to reduce tariff exposure.

These tariff-induced cost pressures also cascade into procurement behavior within hospitals and ambulatory settings. Buyers may place greater emphasis on total acquisition cost and supplier flexibility, and they may welcome value-based contracting that aligns payment with device performance over time. In addition, distributors and e-commerce channels might evolve their inventory strategies to manage currency volatility and tariff pass-through. Ultimately, tariffs will not only influence pricing but also strategic decisions around supply chain resilience, regional manufacturing partnerships, and the relative attractiveness of domestic versus imported offerings, thereby reshaping competitive positioning across the ecosystem.

Comprehensive segmentation perspectives revealing how device type, clinical indication, care setting, distribution pathway, and procedural route determine adoption dynamics

Key segmentation insights reveal differentiated dynamics across device types, clinical applications, end users, distribution channels, and deployment procedures, each shaping adoption and innovation pathways. When analyzed by stent type, the landscape includes bioabsorbable stent, drug-eluting stent, metal stent, and plastic stent, with the metal stent category further distinguishing between covered metal stent and uncovered metal stent; performance trade-offs such as patency duration, migration risk, and retrievability influence clinical preference and device selection criteria. Regarding application, practice patterns differ between benign stricture and malignant stricture, where benign cases include chronic pancreatitis and gallstones and malignant cases include cholangiocarcinoma and pancreatic cancer; these clinical contexts dictate expected device lifespan, complication tolerance, and multidisciplinary care coordination.

In terms of end users, settings encompass ambulatory surgical center, hospital, and specialty clinic, and each presents distinct procurement cycles, inventory constraints, and procedural volumes that affect purchasing decisions. Distribution channels range from direct sales and e-commerce to hospital channel and retail pharmacy, with channel selection influenced by regulatory pathways, reimbursement models, and service expectations. Finally, deployment procedures such as endoscopic retrograde cholangiopancreatography and percutaneous transhepatic cholangiography require different device characteristics and operator competencies, thereby influencing training needs and product design. Taken together, these segmentation layers create a mosaic of clinical and commercial conditions that suppliers must navigate to align product attributes with user requirements and market access strategies.

A regional assessment of how payment models, regulatory diversity, procedural adoption, and local manufacturing shape market access and commercialization strategies

Regional dynamics exert a strong influence on clinical protocols, regulatory pathways, and commercial models across the biliary stent domain. In the Americas, consolidation among hospital systems and an emphasis on bundled payment models encourage solutions that deliver measurable reductions in readmissions and repeat procedures. Clinicians and procurement teams in this region often demand strong post-market evidence and convenient service support, which drives investment in training and lifecycle programs. Conversely, Europe, Middle East & Africa displays heterogeneous regulatory environments and variable payer structures, where local reimbursement rules and infrastructure capacity shape the selection of stent technologies and the pace of adoption.

In Asia-Pacific, rapid adoption of minimally invasive techniques, growing procedural volumes, and strong local manufacturing ecosystems create fertile ground for both established international players and domestic innovators. Across all regions, cross-border supply chain considerations, local production incentives, and differences in procedural guidelines contribute to distinct commercialization strategies. Manufacturers and distributors must therefore tailor market entry approaches, regulatory engagement, and post-sale support to the region-specific needs and constraints in order to secure clinical acceptance and sustainable commercial outcomes.

How device innovation, clinical evidence generation, and integrated service models are shaping the competitive landscape and long-term commercial partnerships

Competitive dynamics in biliary stent systems are driven by the interplay of clinical differentiation, supply chain strength, and the ability to provide comprehensive customer support. Leading firms that invest in device innovation, robust clinical evidence, and integrated training programs secure preferential positions with high-volume centers and specialty networks. At the same time, nimble regional players leverage manufacturing proximity and cost advantages to serve price-sensitive markets and to iterate designs quickly in response to clinician feedback.

Strategic partnerships between device manufacturers, distributors, and healthcare providers are increasingly common, enabling bundled service models and registry collaborations that demonstrate long-term value. Moreover, companies that standardize product interfaces across procedural platforms and offer strong technical support reduce clinician friction and accelerate adoption. From a go-to-market perspective, success often correlates with the ability to synchronize clinical marketing, payer engagement, and supply chain reliability. Consequently, organizations that balance R&D commitments with practical investments in training, evidence generation, and post-market follow-up are positioned to capture durable clinical partnerships and to expand their commercial footprint.

Practical strategic imperatives for manufacturers and suppliers to accelerate adoption, build payer confidence, and fortify supply chain resilience amid evolving market pressures

Industry leaders should prioritize a dual agenda of clinical differentiation and operational resilience to navigate near-term challenges and to capitalize on evolving opportunities. First, invest in real-world evidence programs and multi-center registries that demonstrate outcomes across relevant clinical subsets; this approach will strengthen clinical credibility and support reimbursement discussions. Second, align product development with procedural workflows by engaging key opinion leaders early and by integrating feedback loops that inform iterative design improvements. Third, enhance supply chain flexibility through regional sourcing strategies and contingency planning to mitigate tariff and logistics volatility.

Additionally, firms should expand post-sale services, including modular training packages and remote support capabilities, to reduce clinician onboarding time and to increase procedural consistency. Commercial teams must refine value propositions for different end-user segments by articulating total cost of care benefits rather than unit price alone. Finally, pursue selective partnerships with health systems and distributors to pilot bundled contracting or outcome-linked agreements that de-risk payer adoption and accelerate scale. Taken together, these steps will help companies create durable differentiation while improving adoption velocity and payer alignment.

A transparent, evidence-driven research approach integrating clinician interviews, technical device analyses, and regulatory mapping to support strategic decision-making

This research synthesizes primary and secondary sources through a structured approach that balances clinician insight, commercial intelligence, and technical device evaluation. Primary inputs included interviews with interventional endoscopists, procurement leaders, and device engineers, which provided firsthand perspectives on clinical priorities, device handling considerations, and hospital purchasing behaviors. Secondary inputs encompassed peer-reviewed clinical literature, regulatory filings, product specifications, and industry publications to validate technical claims and to map regulatory pathways. The synthesis prioritized high-quality evidence and cross-validation of assertions to ensure robust conclusions.

Analytical methods combined qualitative thematic analysis with comparative device profiling to identify performance differentiators and operational implications. Regional regulatory and reimbursement frameworks were mapped to align commercialization recommendations with local constraints. Where appropriate, sensitivity checks were applied to reconcile divergent stakeholder views. Throughout the process, emphasis was placed on transparent documentation of sources and analytic assumptions so that decision-makers can trace conclusions back to their evidentiary basis and adapt insights to their specific strategic questions.

A concise synthesis of clinical, operational, and commercial drivers that will determine which players convert innovation into sustained adoption and improved patient outcomes

In conclusion, the biliary stent systems arena is characterized by rapid technical innovation, nuanced clinical differentiation, and intensifying commercial sophistication. New materials and coatings, combined with procedural refinements, are expanding therapeutic possibilities and improving patient outcomes, yet they also require coordinated investments in training, evidence generation, and supply chain adaptability. Tariff dynamics and regional market structures further complicate strategic planning, underscoring the need for flexible sourcing and tailored go-to-market strategies.

Ultimately, stakeholders that align device attributes with specific clinical use cases, invest in post-market evidence, and cultivate operational excellence will be best positioned to lead. Collaboration among manufacturers, clinicians, payers, and distributors will remain essential to translate product innovation into scalable clinical benefit. By focusing on demonstrable patient outcomes and by designing solutions that integrate seamlessly into clinical workflows, organizations can convert technical advances into enduring commercial success and improved standards of care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Covered Biliary Stent System Market, by Stent Type

  • 8.1. Bioabsorbable Stent
  • 8.2. Drug-Eluting Stent
  • 8.3. Metal Stent
    • 8.3.1. Covered Metal Stent
    • 8.3.2. Uncovered Metal Stent
  • 8.4. Plastic Stent

9. Covered Biliary Stent System Market, by Deployment Procedure

  • 9.1. Endoscopic Retrograde Cholangiopancreatography
  • 9.2. Percutaneous Transhepatic Cholangiography

10. Covered Biliary Stent System Market, by Application

  • 10.1. Benign Stricture
    • 10.1.1. Chronic Pancreatitis
    • 10.1.2. Gallstones
  • 10.2. Malignant Stricture
    • 10.2.1. Cholangiocarcinoma
    • 10.2.2. Pancreatic Cancer

11. Covered Biliary Stent System Market, by End User

  • 11.1. Ambulatory Surgical Center
  • 11.2. Hospital
  • 11.3. Specialty Clinic

12. Covered Biliary Stent System Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. E-Commerce
  • 12.3. Hospital Channel
  • 12.4. Retail Pharmacy

13. Covered Biliary Stent System Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Covered Biliary Stent System Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Covered Biliary Stent System Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Covered Biliary Stent System Market

17. China Covered Biliary Stent System Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. B. Braun Melsungen AG
  • 18.6. Boston Scientific Corporation
  • 18.7. CONMED Corporation
  • 18.8. Cook Medical LLC
  • 18.9. ELLA-CS, s.r.o.
  • 18.10. Endo-Flex GmbH
  • 18.11. Fujifilm Holdings Corporation
  • 18.12. Medtronic plc
  • 18.13. Merit Medical Systems, Inc.
  • 18.14. Micro-Tech (Nanjing) Co., Ltd.
  • 18.15. Olympus Corporation
  • 18.16. Taewoong Medical Co., Ltd.
  • 18.17. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL COVERED BILIARY STENT SYSTEM MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY STENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT PROCEDURE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES COVERED BILIARY STENT SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA COVERED BILIARY STENT SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY BIOABSORBABLE STENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY BIOABSORBABLE STENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY BIOABSORBABLE STENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DRUG-ELUTING STENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DRUG-ELUTING STENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DRUG-ELUTING STENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY METAL STENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY METAL STENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY METAL STENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY COVERED METAL STENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY COVERED METAL STENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY COVERED METAL STENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY UNCOVERED METAL STENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY UNCOVERED METAL STENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY UNCOVERED METAL STENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY PLASTIC STENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY PLASTIC STENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY PLASTIC STENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN STRICTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN STRICTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN STRICTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY CHRONIC PANCREATITIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY CHRONIC PANCREATITIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY CHRONIC PANCREATITIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY GALLSTONES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY GALLSTONES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY GALLSTONES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT STRICTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT STRICTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT STRICTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY CHOLANGIOCARCINOMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY CHOLANGIOCARCINOMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY CHOLANGIOCARCINOMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY PANCREATIC CANCER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY PANCREATIC CANCER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY PANCREATIC CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY SPECIALTY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY SPECIALTY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY E-COMMERCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY E-COMMERCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITAL CHANNEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITAL CHANNEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITAL CHANNEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS COVERED BILIARY STENT SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS COVERED BILIARY STENT SYSTEM MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS COVERED BILIARY STENT SYSTEM MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS COVERED BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS COVERED BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS COVERED BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS COVERED BILIARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE COVERED BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE COVERED BILIARY STENT SYSTEM MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE COVERED BILIARY STENT SYSTEM MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE COVERED BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE COVERED BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE COVERED BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE COVERED BILIARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST COVERED BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST COVERED BILIARY STENT SYSTEM MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST COVERED BILIARY STENT SYSTEM MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST COVERED BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST COVERED BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST COVERED BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST COVERED BILIARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. MIDDLE EAST COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC COVERED BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC COVERED BILIARY STENT SYSTEM MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC COVERED BILIARY STENT SYSTEM MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC COVERED BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC COVERED BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC COVERED BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC COVERED BILIARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN COVERED BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN COVERED BILIARY STENT SYSTEM MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. ASEAN COVERED BILIARY STENT SYSTEM MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 151. ASEAN COVERED BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. ASEAN COVERED BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 153. ASEAN COVERED BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 154. ASEAN COVERED BILIARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. ASEAN COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 156. GCC COVERED BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. GCC COVERED BILIARY STENT SYSTEM MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. GCC COVERED BILIARY STENT SYSTEM MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 159. GCC COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 160. GCC COVERED BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. GCC COVERED BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 162. GCC COVERED BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 163. GCC COVERED BILIARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. GCC COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPEAN UNION COVERED BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPEAN UNION COVERED BILIARY STENT SYSTEM MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPEAN UNION COVERED BILIARY STENT SYSTEM MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPEAN UNION COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPEAN UNION COVERED BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPEAN UNION COVERED BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPEAN UNION COVERED BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPEAN UNION COVERED BILIARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPEAN UNION COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS COVERED BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS COVERED BILIARY STENT SYSTEM MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. BRICS COVERED BILIARY STENT SYSTEM MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 177. BRICS COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 178. BRICS COVERED BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. BRICS COVERED BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 180. BRICS COVERED BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 181. BRICS COVERED BILIARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. BRICS COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 183. G7 COVERED BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. G7 COVERED BILIARY STENT SYSTEM MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. G7 COVERED BILIARY STENT SYSTEM MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 186. G7 COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 187. G7 COVERED BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. G7 COVERED BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 189. G7 COVERED BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 190. G7 COVERED BILIARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. G7 COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 192. NATO COVERED BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. NATO COVERED BILIARY STENT SYSTEM MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. NATO COVERED BILIARY STENT SYSTEM MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 195. NATO COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 196. NATO COVERED BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. NATO COVERED BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 198. NATO COVERED BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 199. NATO COVERED BILIARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. NATO COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 201. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. UNITED STATES COVERED BILIARY STENT SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 203. UNITED STATES COVERED BILIARY STENT SYSTEM MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. UNITED STATES COVERED BILIARY STENT SYSTEM MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 205. UNITED STATES COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 206. UNITED STATES COVERED BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 207. UNITED STATES COVERED BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 208. UNITED STATES COVERED BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 209. UNITED STATES COVERED BILIARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 210. UNITED STATES COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 211. CHINA COVERED BILIARY STENT SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 212. CHINA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. CHINA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 214. CHINA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 215. CHINA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 216. CHINA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 217. CHINA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 218. CHINA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. CHINA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)